OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Endocrinology and Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
GLP-1 receptor agonists: an updated review of head-to-head clinical studies	146
Should metformin remain the first-line therapy for treatment of type 2 diabetes?	75
MAFLD: a multisystem disease	57
Role of inflammation in diabetic cardiomyopathy	37
Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use	37
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis	34
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence	32
Insulin resistance in transgender individuals correlates with android fat mass	28
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection	24
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?	23
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data	22
NAFLD in type 1 diabetes: overrated or underappreciated?	20
Diabetes clinic reinvented: will technology change the future of diabetes care?	20
Advancements in the treatment of differentiated thyroid cancer	20
Clinical approaches to treat impaired awareness of hypoglycaemia	19
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications	18
The importance of physical activity in management of type 2 diabetes and COVID-19	18
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis	17
Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study	16
Current updates on protein as biomarkers for diabetic kidney disease: a systematic review	16
Calcitonin: current concepts and differential diagnosis	15
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease	15
Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice	15
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy	15
Digital health and diabetes: experience from India	15

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future	14
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice	14
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus	14
Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures	13
Bone health in transgender people: a narrative review	13
Recent advancement in the treatment of boys and adolescents with hypogonadism	13
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective	12
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes	12
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity	11
Update on genetics and epigenetics in metabolic associated fatty liver disease	11
Therapeutic approaches for non-alcoholic steatohepatitis	10
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol	10
Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling	10
Pharmacological management of severe Cushing’s syndrome: the role of etomidate	9
Menopause, androgens, and cardiovascular ageing: a narrative review	9
RANKL inhibition: a new target of treating diabetes mellitus?	9
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome	9
Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic	9
Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research	9
Should denosumab treatment for osteoporosis be continued indefinitely?	9
Sex and ethnic differences in the cardiovascular complications of type 2 diabetes	8
Emerging pharmacological treatment options for MAFLD	8
Should we undertake surveillance for HCC in patients with MAFLD?	8
Pheochromocytoma: a changing perspective and current concepts	8
Non-pharmacological management options for MAFLD: a practical guide	8
Screening for MAFLD: who, when and how?	8
Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials	8
Impact of TPOAb-negative maternal subclinical hypothyroidism in early pregnancy on adverse pregnancy outcomes	7
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis	7
Relationship between sleep pattern and bone mineral density in patients with osteoporotic fracture	7
Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus	7
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes	7
Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus	7
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease	7
Novel therapeutic targets and agents for pediatric dyslipidemia	6
The management of acute and chronic hyponatraemia	6
Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease	6
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study	6
Gender-affirming endocrine care for youth with a nonbinary gender identity	6
The relation of anatomical distribution of symptomatic peripheral arterial disease (PAD) with HbA1c level in patients with type 2 diabetes mellitus	6
Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors	6
Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China	6
Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials	6
Timing of osteoporosis therapies following fracture: the current status	6
Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review	5
Increased serum calcium levels are associated with carotid atherosclerotic plaque in normocalcaemic individuals with type 2 diabetes	5
Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved?	5
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us	5
Current concept of stress fractures with an additional category of atypical fractures: a perspective review with representative images	5
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome	5

Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?	5
Designing an integrated, nurse-driven and home-based digital intervention to improve insulin management in under-resourced settings	5
The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease	5
Diabetes mellitus in dialysis and renal transplantation	5
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers	4
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes	4
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges	4
Exploring the mechanism of metformin action in Alzheimer’s disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation	4
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study	4
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology	4
Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals	4
Clinical associations with stage B heart failure in adults with type 2 diabetes	3
Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)	3
Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age	3
Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation	3
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis	3
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study	3
Is there a causal relationship between hypothyroidism and hyponatremia?	3
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke	3
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults	3
Epidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions	3
Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic	3
Qualitative evaluation of the symptoms and quality of life impacts of long-chain fatty acid oxidation disorders	3
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis	3